References
- Akanuma Y., Ogawa K., Yamanouchi T., Mashiko S., Oka Y., Kosaka K., Akanuma H. Decreased plasma 1,5-anhydroglucitol in diabetic patients. Diabetes 1981; 30(Suppl. 1)124 A
- Keller U., Viollier E., Schwarz U., Girard J., Berger W. Anwirkungen subkutaner Insulinin-fusionen auf die Stoffwechselkontrolle labiler Diabetiker. Schweiz. med. Wschr. 1980; 110: 1754
- Pickup J. C., Keen H., Parsons J. A., Alberti K. G.M.M., Rowe A. S. Continuous subcutaneous insulin infusion: Improved blood-glucose and intermediary-metabolite control in diabetics. Lancet 1979; i: 1255
- Pietri A., Dunn F. L., Raskin P. The effect of improved diabetic control on plasma lipid and lipoprotein levels. A comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes 1980; 29: 1001
- Pitkänen E. The serum polyol pattern and the urinary polyol excretion in diabetic and in uremic patients. Clin. chim. acta 1972; 38: 221
- Pitkänen E. Occurrence of 1,5-anhydroglucitol in human cerebrospinal fluid. Clin. chim. acta 1973; 48: 159
- Pitkänen E., Hulmi S. Long-term subcutaneous insulin infusion therapy and progression of nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1982; 22: 378
- Pitkänen E., Purokoski S., Lajunen K., Miettinen U. Identification of 1,5-anhydroglucitol in thin-layer chromatograms. Scand. J. clin. Lab. Invest. 1980; 40: 95
- Servo C., Palo J., Pitkanen E. Polyols in the cerebrospinal fluid and plasma of neurological, diabetic and uremic patients. Acta neurol. scand. 1977; 56: 111
- Servo C., Pitkänen E. Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients. Diabetologia 1975; 11: 575
- Smith S. L., Novotny M., Weber E. L. Gas-chromatographic determination of polyol profiles in cerebrospinal fluid. Clin. Chem. 1978; 24: 545
- Steno Study Group. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Lancet 1982; i: 121